Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers

DeucravacitinibOngoingNot yet recruitingPhase 3Open NCT07791199 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…